Brain disorders arise from dysfunction in specific molecular systems and specific circuits. Yet most CNS drugs act broadly across the brain, causing side effects, abuse risk, or complicated delivery without addressing the underlying pathology. We take a different approach. We identify disease-relevant receptor complexes and their molecular context, then design small molecules that selectively modulate pathological signaling where it originates, while preserving healthy brain function.